Introduction

N,N-dimethylformamide (DMF) is a solvent used extensively in the chemical industry. It is commonly used in the manufacture of films, fibers, coatings, and polyurethane lacquers. The annual production of DMF in Japan is reported to be 50,000 tons (1). DMF is absorbed by inhalation and skin contact. It is metabolized by cytochrome P4502E1 to monomethyl and formamide derivatives such as Nhydroxymethyl-N-methylformamide (HMMF) (2). HMMF undergoes thermolytic degradation to form formaldehyde and N-methylformamide (NMF). The urinary concentration of NMF is used for the surveillance of workers exposed to DMF.
The main toxic effects reported after exposure to DMF are gastric irritation, skin eruption and hepatotoxicity. The hepatotoxicity of DMF has been demonstrated in various animal and epidemiological studies (3) (4) (5) (6) (7) (8) (9) (10) (11) . The severity of the liver injury is directly related to dose; however, exposure to DMF can cause symptoms even at low concentrations (12 T a b l e 1 . Cl i n i c a l P r o f i l e s o f t h e P a t i e n t s 
Recovery after removal of DMF (Fig. 2a) . Hepatocytes close to the necrotic area had swollen cytoplasm and varied in nuclear size and number (Fig. 2b) . Enlarged Kupffer cells were present (Fig. 2c) . There was little inflammatory cell infiltration, and steatosis was not evi- 
( a ) Ma s s i v e h e p a t i c n e c r o s i s , ma i n l y i n z o n e 3 ; t h i s a r e a wa s r e p l a c e d b y p o s t n e c r o t i c f i b r o s i s ( S i l v e r s t a i n , × 1 0 0 ) . C: c e n t r a l v e i n , P : p o r t a l v e i n . ( b ) T h e c y t o p l a s m o f s o me h e p a t o c y t e s wa s s wo l l e n . T h e r e wa s l i t t l e i n f l a mmat o r y c e l l i n f i l t r a t i o n ( He ma t o x y l i n a n d E o s i n s t a i n i n g , × 2 0 0 ) . ( c ) E n l a r g e d Ku p f f e r c e l l s c o n t a i n i n g d i a s t a s e -P AS p o s i t i v e ma t e r i a l we r e p r e s e n t , ma i n l y i n z o n e 3 ( d i a s t a s e -P AS s t a i n , × 2 0 0 )
dent. After the patient was discharged from our hospital, he changed his workplace, and liver function tests have remained within normal limits to date. (Fig. 2a-c) . These findings were consistent with those of acute presentation of DMFassociated liver disease (6, 10 (6, 14) , but this finding has not been substantiated by others (9, 15) . There is a possibility that HBV carrier status might have exacerbated the liver injury in case 2. None of the present four patients had excessive alcohol intake or obesity, factors that are also reported to have a synergistic effect with DMF (6, 9, 15) . In addition, although several CYP2E1 polymorphisms have been reported, CYP2E1 insertion polymorphism does not appear to be an important determinant for the interpretation of biological exposure to DMF in Japanese workers (16) .
Case 2
A 46-year-old man developed skin eruptions 5 months before presenting to our institution. At that time his liver function tests were within normal limits, and the eruptions resolved after he changed his workplace. However, after the eruptions resolved, he continued to work at the same place. Five months later, he had a routine health check-up and was referred to a local hospital after describing a 1-month history of nausea. He had no history of hepatic injury, medication use, or excessive alcohol intake. Laboratory examination results showed elevated levels of serum bilirubin (7.6 mg/dL), AST (278 IU/L), ALT (254 IU/L), ALP (339 IU/L) and γ-GTP (196 IU/L). Prothrombin time was prolonged (51.5%). He was an asymptomatic HBV carrier, but his viral levels (<3.7 LGE/mL by transcription-mediated amplification) were undetectable. HBe antigen was negative and antiHBe was positive in sera. Urine NMF level was as high as 158.5 mg/dL. He was admitted to the hospital, and his liver function tests normalized without any specific treatment.
Case 3
A 25-year-old man developed skin eruptions 10 days after he started a new job. He had no other symptoms such as jaundice and general malaise. He had no history of hepatic injury, medication use, or excessive alcohol intake. Laboratory tests indicated elevated levels of serum AST (196 IU/ L), ALT (491 IU/L), ALP (416 IU/L) and γ-GTP (374 IU/ L). Liver injury due to HBV or HCV was ruled out on the basis of serological investigations. Urine NMF level was 2.4 mg/dL. The liver dysfunction spontaneously recovered after the patient changed his workplace.
Case 4 A 37-year-old man developed skin eruptions 15 days after he started a new job. No other symptoms were present and he had no history of hepatic injury, medication use, or excessive alcohol intake. Laboratory tests showed elevated levels of AST (266 IU/L), ALT (595 IU/L), and γ-GTP (88 IU/ L). The liver function tests normalized after he changed his workplace.
Discussion
In 
